S-EPMC10565379 - Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity. - OmicsDI

Unknown

Dataset Information

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity.

ABSTRACT:

SUBMITTER: Wang Z

PROVIDER: S-EPMC10565379 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature